The plastic bottle you just tossed in the recycling bin could provide structural support for your future house. MIT engineers ...

Floating shelves work well in any space, frankly, but they are particularly useful in the bathroom where horizontal surfaces ...

Pontoon boats are everywhere these days. Here are eight different pontoons that can satisfy your boating needs. The post ...

The recommended target for protein intake increased from 0.8 g/kg/day to 1.2-1.6 g/kg/day in 2026. Individual protein requirements vary by age, sex, and physical activity.

PXG’s GEN8 irons rethink iron design with perimeter-based weighting, forged construction and three models built for distinct player types.

Analysis finds those who stopped using medication saw weight return four times faster compared with other weight loss plans People who stop taking weight loss jabs regain all the weight originally ...

People who stop taking weight-loss drugs tend to regain the weight they lost within less than two years, according to a study of more than 9000 people. Some argue that this emphasises that obesity is ...

First and only GLP-1 pill on the market costs significantly less than injectable versions The first pill version of the blockbuster GLP-1 weight loss drugs has been launched in the US by Novo Nordisk ...

Danish pharmaceutical giant Novo Nordisk announced Monday the US Food and Drug Administration (FDA) had approved its popular GLP-1 anti-obesity drug Wegovy to be administered in pill form for weight ...

In some studies, half of patients stopped taking GLP-1s within a year despite the benefits, citing the expense and side effects. By Paula Span Year after year, Mary Bucklew strategized with a ...

The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug. By Gina Kolata Gina Kolata has ...

(NEXSTAR) – The World Health Organization has issued new guidance on the use of popular GLP-1 drugs, like Ozempic, Wegovy, Mounjaro, and Zepbound, to treat the “major global health challenge” of ...